P Pakarinen

No ORCID on file · 5 papers in corpus · active 1995-2003

Study types

  • article 4
  • review 1

Condition tags

  • endometriosis 4
  • dysmenorrhea 1
  • infertility 1
  • adenomyosis 1
article 2003
Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis
Human Reproduction ·doi:10.1093/humrep/deg179

BACKGROUND: The levonorgestrel-releasing intra-uterine system (LNg-IUS) has been used to control menorrhagia, but irregular bleeding during the first 3 months of use was the most notable side effect. Endometrial angiogenesis is believed to …

article 2002
Lack of association of the common immunologically anomalous LH with endometriosis
Human Reproduction ·doi:10.1093/humrep/17.6.1532

BACKGROUND: Subfertile women with endometriosis have been reported to demonstrate impaired follicular growth, ovulatory dysfunction and disturbed LH patterns. In addition, abnormal LH and/or LH receptors have been linked with endometriosis-…

article 2001
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium
Human Reproduction ·doi:10.1093/humrep/16.10.2103

BACKGROUND: The levonorgestrel-releasing intrauterine system (LNg-IUS) has been shown to be effective in the management of menorrhagia. In order to evaluate the effects of LNg-IUS on endometrial proliferation and apoptosis, proliferating ce…

review 2001
Therapeutic Use of the LNG IUS, and Counseling
Seminars in reproductive medicine ·doi:10.1055/s-2001-18644

The intrauterine release of levonorgestrel (LNG) alters the function of the endometrium. This phenomenon offers special health benefits for users and a manner of local intrauterine therapy. In this review we discuss use of LNG-releasing int…

article 1995
Uterus and endometrium: The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation
·doi:10.1093/oxfordjournals.humrep.a136305

To evaluate non-invasively the role of levonorgestrel releasing devices in direct contact with the endometrium on menstrual spotting and endometrium inactivation, we inserted levonorgestrel releasing devices (20 micrograms/24 h) either into…